Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Umbilical Cord Blood Transplantation: Challenges and Future Directions.

Ballen K.

Stem Cells Transl Med. 2017 May;6(5):1312-1315. doi: 10.1002/sctm.17-0069.

2.

A preclinical evaluation of alternative site for islet allotransplantation.

Wang C, Du X, He S, Yuan Y, Han P, Wang D, Chen Y, Liu J, Tian B, Yang G, Yi S, Gao F, Zhong Z, Li H, Cheng J, Lu Y.

PLoS One. 2017 Mar 30;12(3):e0174505. doi: 10.1371/journal.pone.0174505. eCollection 2017.

3.

Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells).

Perucca S, Di Palma A, Piccaluga PP, Gemelli C, Zoratti E, Bassi G, Giacopuzzi E, Lojacono A, Borsani G, Tagliafico E, Scupoli MT, Bernardi S, Zanaglio C, Cattina F, Cancelli V, Malagola M, Krampera M, Marini M, Almici C, Ferrari S, Russo D.

PLoS One. 2017 Feb 23;12(2):e0172430. doi: 10.1371/journal.pone.0172430. eCollection 2017.

4.

Bone Marrow Cell Trafficking Analyzed by 89Zr-oxine Positron Emission Tomography in a Murine Transplantation Model.

Asiedu KO, Koyasu S, Szajek LP, Choyke PL, Sato N.

Clin Cancer Res. 2017 Jun 1;23(11):2759-2768. doi: 10.1158/1078-0432.CCR-16-1561. Epub 2016 Dec 13.

PMID:
27965305
5.

Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells.

Metheny L 3rd, Eid S, Lingas K, Reese J, Meyerson H, Tong A, de Lima M, Huang AY.

Hematol Med Oncol. 2016;1(1):25-29. Epub 2016 Oct 20.

6.

Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.

Cavazzana M, Ribeil JA, Lagresle-Peyrou C, André-Schmutz I.

Stem Cells Dev. 2017 Jan 15;26(2):71-76. doi: 10.1089/scd.2016.0230. Epub 2016 Oct 16.

PMID:
27750026
7.

Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT.

Paviglianiti A, Xavier E, Ruggeri A, Ceballos P, Deconinck E, Cornelissen JJ, Nguyen-Quoc S, Maillard N, Sanz G, Rohrlich PS, Garderet L, Volt F, Rocha V, Kroeger N, Gluckman E, Fegueux N, Mohty M.

Haematologica. 2016 Sep;101(9):1120-7. doi: 10.3324/haematol.2015.138917. Epub 2016 May 26.

8.

How to Improve Cord Blood Engraftment?

Beksac M, Yurdakul P.

Front Med (Lausanne). 2016 Feb 17;3:7. doi: 10.3389/fmed.2016.00007. eCollection 2016. Review.

9.

Alternative Donor Transplantation for Acute Myeloid Leukemia.

Bejanyan N, Haddad H, Brunstein C.

J Clin Med. 2015 Jun 9;4(6):1240-68. doi: 10.3390/jcm4061240. Review.

10.
11.
12.

Concise review: umbilical cord blood transplantation: past, present, and future.

Munoz J, Shah N, Rezvani K, Hosing C, Bollard CM, Oran B, Olson A, Popat U, Molldrem J, McNiece IK, Shpall EJ.

Stem Cells Transl Med. 2014 Dec;3(12):1435-43. doi: 10.5966/sctm.2014-0151. Epub 2014 Nov 5. Review.

13.

Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.

Solh M.

World J Stem Cells. 2014 Sep 26;6(4):371-9. doi: 10.4252/wjsc.v6.i4.371. Review.

14.

Superselective intra-arterial umbilical cord blood administration to BM in experimental animals.

Arnberg F, Lundberg J, Kenne E, Jaff N, Müller P, Nava S, Kaipe H, Ringdén O, Holmin S.

Bone Marrow Transplant. 2014 Dec;49(12):1486-91. doi: 10.1038/bmt.2014.190. Epub 2014 Sep 8.

15.

Clinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in Korea.

Lee YH.

Korean J Pediatr. 2014 Mar;57(3):110-6. doi: 10.3345/kjp.2014.57.3.110. Epub 2014 Mar 31. Review.

16.

Prolonged Survival of a Refractory Acute Myeloid Leukemia Patient after a Third Hematopoietic Stem Cell Transplantation with Umbilical Cord Blood following a Second Relapse.

Lee SY, Kurita N, Maie K, Seki M, Yokoyama Y, Suzukawa K, Hasegawa Y, Chiba S.

Case Rep Hematol. 2014;2014:918708. doi: 10.1155/2014/918708. Epub 2014 Feb 9.

17.

Improving engraftment and immune reconstitution in umbilical cord blood transplantation.

Danby R, Rocha V.

Front Immunol. 2014 Feb 24;5:68. doi: 10.3389/fimmu.2014.00068. eCollection 2014. Review.

18.

Background and future considerations for human cord blood hematopoietic cell transplantation, including economic concerns.

Broxmeyer HE, Farag S.

Stem Cells Dev. 2013 Dec;22 Suppl 1:103-10. doi: 10.1089/scd.2013.0382. Review.

19.

Cord Blood Transplantation: Can We Make it Better?

Metheny L, Caimi P, de Lima M.

Front Oncol. 2013 Sep 17;3:238. doi: 10.3389/fonc.2013.00238. Review.

20.

Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation.

Cutler C, Multani P, Robbins D, Kim HT, Le T, Hoggatt J, Pelus LM, Desponts C, Chen YB, Rezner B, Armand P, Koreth J, Glotzbecker B, Ho VT, Alyea E, Isom M, Kao G, Armant M, Silberstein L, Hu P, Soiffer RJ, Scadden DT, Ritz J, Goessling W, North TE, Mendlein J, Ballen K, Zon LI, Antin JH, Shoemaker DD.

Blood. 2013 Oct 24;122(17):3074-81. doi: 10.1182/blood-2013-05-503177. Epub 2013 Aug 30.

Supplemental Content

Support Center